Document Detail


Osteoporosis. ACOG technical bulletin number 167--May 1992.
MedLine Citation:
PMID:  8102995     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Osteoporosis is currently better prevented than treated, and the efforts of the physician should be aimed at prevention. Small-framed, white and Asian, hypoestrogenic women with life style factors or medical conditions associated with impaired calcium metabolism or increased bone loss have the greatest risk of developing osteoporosis. Estrogen therapy in the hypoestrogenic woman has a significant protective benefit. Bone density studies are now available for at-risk patients to detect the presence or development of bone loss. Therapy can now be instituted before significant bone loss has occurred.
Authors:
-
Related Documents :
9692075 - Does vitamin d strengthen the increase in femoral neck bmd in osteoporotic women treate...
15118265 - Effects of aging and postmenopausal hypoestrogenism on skin elasticity and bone mineral...
15739035 - Bsmi vitamin d receptor genotypes influence the efficacy of antiresorptive treatments i...
6106785 - Skeletal uptake of diphosphonate. method for prediction of post-menopausal osteoporosis.
24411285 - Usefulness of the seattle heart failure model to identify adults with congenital heart ...
18685505 - Evaluation of prebiotic potential of refined psyllium (plantago ovata) fiber in healthy...
Publication Detail:
Type:  Guideline; Journal Article; Practice Guideline    
Journal Detail:
Title:  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics     Volume:  41     ISSN:  0020-7292     ISO Abbreviation:  Int J Gynaecol Obstet     Publication Date:  1993 Jun 
Date Detail:
Created Date:  1993-09-28     Completed Date:  1993-09-28     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0210174     Medline TA:  Int J Gynaecol Obstet     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  291-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Absorptiometry, Photon
Calcitonin / therapeutic use
Estrogen Replacement Therapy
Etidronic Acid / therapeutic use
Female
Humans
Incidence
Nutritional Requirements
Osteoporosis, Postmenopausal* / diagnosis,  epidemiology,  etiology,  therapy
Risk Factors
Chemical
Reg. No./Substance:
2809-21-4/Etidronic Acid; 9007-12-9/Calcitonin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pregnancy after liver transplantation.
Next Document:  Cardiac disease in pregnancy. ACOG technical bulletin number 168--June 1992.